China women health diagnostics market is growing at a CAGR of approximately 10.0% during the forecast period. China is one of the major countries in the women healthcare diagnostics market. China is one of the fastest-growing economies of the world with a GDP of over $21.3 trillion, with around $ 15,400 per capita. Increasing healthcare infrastructure in China is one of the major factors that is driving the growth of the China women health diagnostics market. Total per capita expenditure in China was estimated to be around 5.5% of the overall GDP of the country. All major cities have hospitals and healthcare centers specializing in various fields and are equipped with some modern facilities. These are the major factors that are backing the growth of the china women health diagnostic market during the forecast period.
To Request a Sample of our Report on China Women Health Diagnostics Market: https://www.omrglobal.com/request-sample/china-women-health-diagnostics-market
Further, cancer incidences and mortality have been augmented in China, making cancer a major public health problem in the country and the leading cause of mortality since the last decade. This rising burden is caused by the overgrowing population, sociodemographic changes. According to CDC, it is estimated that there will be about 4.3 million new cancer cases and 2.9 million new cancer deaths were recorded in 2018 in China, which can be prevented by early detection and treatment. Among women, the most common cancers are lung and bronchus, stomach, colorectal, breast, and esophagus, accounting for around 60% of all cases. Breast cancer alone is anticipated to account for 15% of all new cancers in women in China. Thus, all these factors lead to the growth of the China women health diagnostic market during the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of China Women Health Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/china-women-health-diagnostics-market
China Women Health Diagnostics Market Segmentation
By Applications
- Breast Cancer Testing
- Cervical Cancer Testing
- Pregnancy & Fertility Testing
- Ovarian Cancer Testing
- Infectious Disease Testing
- Ultrasound Tests
- Sexually Transmitted Disease Testing
- Others (Osteoporosis Testing and Prenatal Genetic Testing)
By End-User
- Diagnostic and Imaging Centers
- Hospitals and Clinics
- Home Care
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
